Royalty Pharma plc Class A Ordinary Shares vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $330.98M). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 76.3× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Roundhill S&P 500 0DTE Covered Call Strategy ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royalty Pharma plc Class A Ordinary Shares for 0 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| RPRX | XDTE | |
|---|---|---|
Market Cap | $25.27B | $330.98M |
Volume | 3,671,183 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $63.96 | $44.76 |
52-Week Low | $35.44 | $36.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $32.50B | — |
Dividend Yield | 1.66% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →